LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10045-1 | A443654 | LSM-1045 | 10172943 | ||
10133-1 | Afatinib | BIBW-2992 | LSM-43226 | 57519523 | |
10233-1 | Alpelisib | BYL719 | LSM-4256 | 56649450 | |
10011-1 | Alvocidib | Flavopiridol; HMR-1275; L868275 | LSM-1011 | 5287969 | |
10004-1 | AT-7519 | LSM-1004 | 11338033 | ||
10158-1 | AZD 5438 | KIN001-239 | LSM-1159 | 16747683 | |
10059-1 | AZD-6482 | KIN001-193 | LSM-1059 | 44137675 | |
10006-1 | AZD7762 | LSM-1006 | 67077825 | ||
10007-1 | AZD8055 | LSM-1007 | 25262965 | ||
10164-1 | AZD8330 | ARRY-424704; ARRY-704 | LSM-1165 | 16666708 | |
10067-1 | Barasertib | AZD1152-HQPA | LSM-1067 | 16007391 | |
10041-1 | BI-2536 | NPK33-1-98-1 | LSM-1041 | 11364421 | |
10028-1 | BMS345541 | LSM-1028 | 9813758 | ||
10177-1 | Brivanib | BMS-540215 | LSM-1178 | 11451527 | |
10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 | 16654980 | |
10055-1 | BX-912 | LSM-1055 | 11754511 | ||
10120-1 | Canertinib | CI-1033; PD-183805 | LSM-1120 | 156414 | |
10117-1 | Celastrol | LSM-1117 | 5315765 | ||
10025-1 | CGP60474 | MLS000911536; SMR000463552 | LSM-1025 | 644215 | |
10180-1 | CHIR-99021 | CT99021; KIN001-157 | LSM-1181 | 9956119 | |
10009-1 | CP466722 | LSM-1009 | 44551660 | ||
10010-1 | CP724714 | LSM-42777 | 53401057 | ||
10027-1 | Crizotinib | PF02341066 | LSM-1027 | 11626560 | |
10232-1 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 | 3062316 |